SCHEMBL7042896

SCHEMBL7042896

Oc1ccc(-c2[nH]c3cc(O)ccc3c2-c2ccc(O)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.71
ESR2 Q92731 4/20 0.71
PTGS2 P35354 2/20 0.54
PDPK1 O15530 1/20 0.47
HSP90AB1 P08238 1/20 0.47
MAPK14 Q16539 4/20 0.46
MAPK13 O15264 3/20 0.46
MAPK12 P53778 3/20 0.46
MAPK11 Q15759 3/20 0.46
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 4/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
GLI1 P08151 1/20 0.42
GLI2 P10070 1/20 0.42
MEN1 O00255 3/20 0.42
CASP1 P29466 3/20 0.42
CASP7 P55210 3/20 0.42
KMT2A Q03164 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038621 0.93 ESR1 (0.79) ESR1ESR2PTGS2MAPK14MAPK13
SCHEMBL7042915 0.93 ESR1 (0.79) ESR1ESR2PTGS2MAPK14MAPK13
SCHEMBL5193971 0.89 ESR1 (0.73) ESR1ESR2PTGS2KDM4EALDH1A1
SCHEMBL7038838 0.86 ESR1 (0.63) ESR1ESR2PTGS2CYP3A4BLM
SCHEMBL7037980 0.83 ESR1 (1.00) ESR1ESR2PTGS2MAPK14
SCHEMBL7039129 0.81 ESR1 (0.61) ESR1ESR2PTGS2MAPK14MAPK13
SCHEMBL7040440 0.80 ESR1 (1.00) ESR1ESR2PTGS2MAPK14KDM4E
SCHEMBL31060913 0.80 ESR1 (1.00) ESR1ESR2PTGS2MAPK14KDM4E
SCHEMBL28383145 0.80 NR1I2 (0.58) ESR1ESR2PDPK1HSP90AB1KDM4E
SCHEMBL7041571 0.80 ESR1 (1.00) ESR1ESR2PTGS2MAPK14KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030220377-A1 Indole compounds and their use as estrogen agonists/antagonists CHESWORTH RICHARD (US) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220377-A1 Indole compounds and their use as estrogen agonists/antagonists ESR1, GPER1, ESR2 ESR1 1/4885ESR2 3/4885PTGS2 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.